| Year |
Citation |
Score |
| 2013 |
Yaghmaei S, Roberts C, Ai R, Mizwicki MT, Chang CE. Agonist and antagonist binding to the nuclear vitamin D receptor: dynamics, mutation effects and functional implications. In Silico Pharmacology. 1: 2. PMID 25505647 DOI: 10.1186/2193-9616-1-2 |
0.604 |
|
| 2013 |
Mizwicki MT, Liu G, Fiala M, Magpantay L, Sayre J, Siani A, Mahanian M, Weitzman R, Hayden EY, Rosenthal MJ, Nemere I, Ringman J, Teplow DB. 1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients. Journal of Alzheimer's Disease : Jad. 34: 155-70. PMID 23186989 DOI: 10.3233/Jad-121735 |
0.497 |
|
| 2013 |
Sequeira VB, Rybchyn MS, Gordon-Thomson C, Tongkao-on W, Mizwicki MT, Norman AW, Reeve VE, Halliday GM, Mason RS. Opening of chloride channels by 1α,25-dihydroxyvitamin D3 contributes to photoprotection against UVR-induced thymine dimers in keratinocytes. The Journal of Investigative Dermatology. 133: 776-82. PMID 23014341 DOI: 10.1038/Jid.2012.343 |
0.708 |
|
| 2012 |
Mizwicki MT, Menegaz D, Zhang J, Barrientos-Durán A, Tse S, Cashman JR, Griffin PR, Fiala M. Genomic and nongenomic signaling induced by 1α,25(OH)2-vitamin D3 promotes the recovery of amyloid-β phagocytosis by Alzheimer's disease macrophages. Journal of Alzheimer's Disease : Jad. 29: 51-62. PMID 22207005 DOI: 10.3233/Jad-2012-110560 |
0.619 |
|
| 2011 |
Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms. Best Practice & Research. Clinical Endocrinology & Metabolism. 25: 543-59. PMID 21872797 DOI: 10.1016/J.Beem.2011.05.010 |
0.715 |
|
| 2011 |
Menegaz D, Mizwicki MT, Barrientos-Duran A, Chen N, Henry HL, Norman AW. Vitamin D receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP). Molecular Endocrinology (Baltimore, Md.). 25: 1289-300. PMID 21659475 DOI: 10.1210/Me.2010-0442 |
0.783 |
|
| 2011 |
Fiala M, Mahanian M, Rosenthal M, Mizwicki MT, Tse E, Cho T, Sayre J, Weitzman R, Porter V. MGAT3 mRNA: a biomarker for prognosis and therapy of Alzheimer's disease by vitamin D and curcuminoids. Journal of Alzheimer's Disease : Jad. 25: 135-44. PMID 21368380 DOI: 10.3233/JAD-2011-101950 |
0.344 |
|
| 2011 |
Fiala M, Mizwicki MT. Neuroprotective and immune effects of active forms of vitamin D3 and docosahexaenoic acid in Alzheimer disease patients Functional Foods in Health and Disease. 1: 545. DOI: 10.31989/FFHD.V1I12.107 |
0.495 |
|
| 2011 |
Mizwicki MT, Norman AW. Vitamin D sterol/VDR conformational dynamics and nongenomic actions Vitamin D. 271-297. DOI: 10.1016/B978-0-12-381978-9.10015-0 |
0.721 |
|
| 2010 |
Kakuda S, Ishizuka S, Eguchi H, Mizwicki MT, Norman AW, Takimoto-Kamimura M. Structural basis of the histidine-mediated vitamin D receptor agonistic and antagonistic mechanisms of (23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone. Acta Crystallographica. Section D, Biological Crystallography. 66: 918-26. PMID 20693691 DOI: 10.1107/S0907444910020810 |
0.684 |
|
| 2010 |
Mason RS, Sequeira VB, Dixon KM, Gordon-Thomson C, Pobre K, Dilley A, Mizwicki MT, Norman AW, Feldman D, Halliday GM, Reeve VE. Photoprotection by 1alpha,25-dihydroxyvitamin D and analogs: further studies on mechanisms and implications for UV-damage. The Journal of Steroid Biochemistry and Molecular Biology. 121: 164-8. PMID 20399269 DOI: 10.1016/J.Jsbmb.2010.03.082 |
0.639 |
|
| 2010 |
Mizwicki MT, Menegaz D, Yaghmaei S, Henry HL, Norman AW. A molecular description of ligand binding to the two overlapping binding pockets of the nuclear vitamin D receptor (VDR): structure-function implications. The Journal of Steroid Biochemistry and Molecular Biology. 121: 98-105. PMID 20398762 DOI: 10.1016/J.Jsbmb.2010.04.005 |
0.79 |
|
| 2010 |
Menegaz D, Barrientos-Duran A, Kline A, Silva FR, Norman AW, Mizwicki MT, Zanello LP. 1alpha,25(OH)2-Vitamin D3 stimulation of secretion via chloride channel activation in Sertoli cells. The Journal of Steroid Biochemistry and Molecular Biology. 119: 127-34. PMID 20156558 DOI: 10.1016/J.Jsbmb.2010.01.011 |
0.736 |
|
| 2009 |
Mizwicki MT, Bula CM, Mahinthichaichan P, Henry HL, Ishizuka S, Norman AW. On the mechanism underlying (23S)-25-dehydro-1alpha(OH)-vitamin D3-26,23-lactone antagonism of hVDRwt gene activation and its switch to a superagonist. The Journal of Biological Chemistry. 284: 36292-301. PMID 19801650 DOI: 10.1074/Jbc.M109.042069 |
0.826 |
|
| 2009 |
Mizwicki MT, Norman AW. The vitamin D sterol-vitamin D receptor ensemble model offers unique insights into both genomic and rapid-response signaling. Science Signaling. 2: re4. PMID 19531804 DOI: 10.1126/Scisignal.275Re4 |
0.775 |
|
| 2007 |
Mizwicki MT, Bula CM, Bishop JE, Norman AW. New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model. The Journal of Steroid Biochemistry and Molecular Biology. 103: 243-62. PMID 17368177 DOI: 10.1016/J.Jsbmb.2006.12.004 |
0.798 |
|
| 2005 |
Mizwicki MT, Bula CM, Bishop JE, Norman AW. A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols. The Journal of Steroid Biochemistry and Molecular Biology. 97: 69-82. PMID 16055325 DOI: 10.1016/J.Jsbmb.2005.06.025 |
0.841 |
|
| 2005 |
Miura D, Norman AW, Mizwicki MT, Fujishima T, Konno K, Kittaka A, Takayama H, Ishizuka S. The antagonism between 2-methyl-1,25-dihydroxyvitamin D3 and 2-methyl-20-epi-1,25-dihydroxyvitamin D3 in non-genomic pathway-mediated biological responses induced by 1alpha,25-dihydroxyvitamin D3 assessed by NB4 cell differentiation. The Journal of Steroid Biochemistry and Molecular Biology. 94: 469-79. PMID 15876412 DOI: 10.1016/J.Jsbmb.2005.01.025 |
0.694 |
|
| 2005 |
Mizwicki MT, Bishop JE, Norman AW. Applications of the Vitamin D sterol-Vitamin D receptor (VDR) conformational ensemble model. Steroids. 70: 464-71. PMID 15862832 DOI: 10.1016/J.Steroids.2005.03.003 |
0.834 |
|
| 2004 |
Mizwicki MT, Keidel D, Bula CM, Bishop JE, Zanello LP, Wurtz JM, Moras D, Norman AW. Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH) 2-vitamin D3 signaling Proceedings of the National Academy of Sciences of the United States of America. 101: 12876-12881. PMID 15326291 DOI: 10.1073/Pnas.0403606101 |
0.838 |
|
| 2004 |
Mizwicki MT, Bishop JE, Olivera CJ, Huhtakangas J, Norman AW. Evidence that annexin II is not a putative membrane receptor for 1alpha,25(OH)2-vitamin D3. Journal of Cellular Biochemistry. 91: 852-63. PMID 14991775 DOI: 10.1002/Jcb.10783 |
0.778 |
|
| 2004 |
Norman AW, Mizwicki MT, Norman DP. Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nature Reviews. Drug Discovery. 3: 27-41. PMID 14708019 DOI: 10.1038/Nrd1283 |
0.547 |
|
| 2003 |
Norman AW, Mizwicki MT, Okamura WH. Ligand structure-function relationships in the vitamin D endocrine system from the perspective of drug development (including cancer treatment). Recent Results in Cancer Research. Fortschritte Der Krebsforschung. ProgrèS Dans Les Recherches Sur Le Cancer. 164: 55-82. PMID 12899514 |
0.712 |
|
| 2003 |
Mizwicki MT, Norman AW. Two key proteins of the vitamin D endocrine system come into crystal clear focus: comparison of the X-ray structures of the nuclear receptor for 1alpha,25(OH)2 vitamin D3, the plasma vitamin D binding protein, and their ligands. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 18: 795-806. PMID 12733718 DOI: 10.1359/Jbmr.2003.18.5.795 |
0.768 |
|
| 2002 |
Norman AW, Bishop JE, Bula CM, Olivera CJ, Mizwicki MT, Zanello LP, Ishida H, Okamura WH. Molecular tools for study of genomic and rapid signal transduction responses initiated by 1 alpha,25(OH)(2)-vitamin D(3). Steroids. 67: 457-66. PMID 11960621 DOI: 10.1016/S0039-128X(01)00167-2 |
0.71 |
|
| Show low-probability matches. |